Dashboard
Manage Tickers

RVTYREVVITY, INC.

NYSE perkinelmer.com


$ 122.82 $ 0.77 (0.63 %)    

Monday, 16-Sep-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 122.8
$ 122.39
$ 121.51 x 100
$ 125.02 x 100
$ 121.64 - $ 123.57
$ 79.34 - $ 128.15
608,191
na
15.15B
$ 0.87
$ 89.39
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-07-2023 10-01-2023 10-Q
5 08-09-2023 07-02-2023 10-Q
6 05-12-2023 04-02-2023 10-Q
7 03-01-2023 01-01-2023 10-K
8 11-14-2022 10-02-2022 10-Q
9 08-09-2022 07-03-2022 10-Q
10 05-10-2022 04-03-2022 10-Q
11 03-03-2022 01-02-2022 10-K
12 11-09-2021 10-03-2021 10-Q
13 08-10-2021 07-04-2021 10-Q
14 05-11-2021 04-04-2021 10-Q
15 03-02-2021 01-03-2021 10-K
16 11-10-2020 10-04-2020 10-Q
17 08-11-2020 07-05-2020 10-Q
18 05-12-2020 04-05-2020 10-Q
19 02-25-2020 12-29-2019 10-K
20 11-05-2019 09-29-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-07-2019 03-31-2019 10-Q
23 02-26-2019 12-30-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-07-2018 07-01-2018 10-Q
26 05-08-2018 04-01-2018 10-Q
27 02-27-2018 12-31-2017 10-K
28 11-07-2017 10-01-2017 10-Q
29 08-08-2017 07-02-2017 10-Q
30 05-09-2017 04-02-2017 10-Q
31 02-28-2017 01-01-2017 10-K
32 11-08-2016 10-02-2016 10-Q
33 08-09-2016 07-03-2016 10-Q
34 05-10-2016 04-03-2016 10-Q
35 03-01-2016 01-03-2016 10-K
36 11-10-2015 10-04-2015 10-Q
37 08-04-2015 06-28-2015 10-Q
38 05-05-2015 03-29-2015 10-Q
39 02-24-2015 12-28-2014 10-K
40 11-04-2014 09-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

looking-into-revvitys-recent-short-interest
Looking Into Revvity's Recent Short Interest
09/10/2024 18:30:13

wells-fargo-initiates-coverage-on-revvity-with-equal-weight-rating-announces-price-target-of-130
Wells Fargo Initiates Coverage On Revvity ...
08/27/2024 21:48:34

Wells Fargo analyst Brandon Couillard initiates coverage on Revvity (NYSE:RVTY) with a Equal-Weight rating and announces Pri...

td-cowen-maintains-buy-on-revvity-raises-price-target-to-141
TD Cowen Maintains Buy on Revvity, Raises ...
07/30/2024 16:14:05

TD Cowen analyst Dan Brennan maintains Revvity (NYSE:RVTY) with a Buy and raises the price target from $130 to $141.

citigroup-maintains-buy-on-revvity-raises-price-target-to-145
Citigroup Maintains Buy on Revvity, Raises...
07/30/2024 14:57:18

Citigroup analyst Patrick Donnelly maintains Revvity (NYSE:RVTY) with a Buy and raises the price target from $135 to $145.

jp-morgan-maintains-neutral-on-revvity-raises-price-target-to-120
JP Morgan Maintains Neutral on Revvity, Ra...
07/30/2024 13:01:11

JP Morgan analyst Rachel Vatnsdal maintains Revvity (NYSE:RVTY) with a Neutral and raises the price target from $105 to $120.

barclays-maintains-equal-weight-on-revvity-raises-price-target-to-125
Barclays Maintains Equal-Weight on Revvity...
07/30/2024 12:02:56

Barclays analyst Luke Sergott maintains Revvity (NYSE:RVTY) with a Equal-Weight and raises the price target from $115 to $125.

b-of-a-securities-maintains-neutral-on-revvity-raises-price-target-to-127
B of A Securities Maintains Neutral on Rev...
07/30/2024 11:11:38

B of A Securities analyst Derik De Bruin maintains Revvity (NYSE:RVTY) with a Neutral and raises the price target from $118 ...

jefferies-maintains-hold-on-revvity-raises-price-target-to-125
Jefferies Maintains Hold on Revvity, Raise...
07/29/2024 21:15:12

Jefferies analyst Tycho Peterson maintains Revvity (NYSE:RVTY) with a Hold and raises the price target from $115 to $125.

wall-street-rises-ahead-of-big-tech-earnings-fed-meeting-tesla-rebounds-oil-prices-drop-to-7-week-lows-whats-driving-markets-monday
Wall Street Rises Ahead Of Big Tech Earnin...
07/29/2024 17:31:07

Wall Street opened higher at the start of a data-heavy week, with traders adopting an optimistic tone ahead of crucial earnings...

life-science-firm-revvity-lifts-annual-profit-forecast-on-strong-q2-performance
Life Science Firm Revvity Lifts Annual Pro...
07/29/2024 14:38:34

Revvity reported Q2 sales of $691.69 million, surpassing estimates, with adjusted EPS of $1.22. Life Sciences revenue fell 7%, ...

revvity-updates-its-2024-adjusted-eps-guidance-to--470-480-compared-to-prior-guidance-of--455-475-and-consensus-of-463
Revvity Updates Its 2024 Adjusted EPS Guid...
07/29/2024 10:07:07

revvity-updates-its-2024-sales-guidance-to-277b-279b-compared-to-prior-guidance-of-276b-282b-and-consensus-of-2793b
Revvity Updates Its 2024 Sales Guidance To...
07/29/2024 10:05:56

revvity-q2-2024-adj-eps-122-beats-112-estimate-sales-691685m-beat-690356m-estimate
Revvity Q2 2024 Adj EPS $1.22 Beats $1.12 ...
07/29/2024 10:01:20

leerink-partners-initiates-coverage-on-revvity-with-outperform-rating-announces-price-target-of-125
Leerink Partners Initiates Coverage On Rev...
07/08/2024 10:43:23

Leerink Partners initiates coverage on Revvity (NYSE:RVTY) with a Outperform rating and announces Price Target of $125.

barclays-maintains-equal-weight-on-revvity-lowers-price-target-to-115
Barclays Maintains Equal-Weight on Revvity...
06/28/2024 15:56:36

Barclays analyst Luke Sergott maintains Revvity (NYSE:RVTY) with a Equal-Weight and lowers the price target from $116 to $115.

baird-maintains-outperform-on-revvity-raises-price-target-to-127
Baird Maintains Outperform on Revvity, Rai...
04/30/2024 16:08:17

Baird analyst Catherine Ramsey maintains Revvity (NYSE:RVTY) with a Outperform and raises the price target from $126 to $127.

4-analysts-have-this-to-say-about-revvity
4 Analysts Have This To Say About Revvity
04/30/2024 16:01:17

td-cowen-maintains-buy-on-revvity-raises-price-target-to-130
TD Cowen Maintains Buy on Revvity, Raises ...
04/30/2024 15:18:50

TD Cowen analyst Dan Brennan maintains Revvity (NYSE:RVTY) with a Buy and raises the price target from $123 to $130.

us-stocks-kick-off-the-week-in-the-green-tesla-rockets-on-chinas-fsd-approval-yen-rallies-whats-driving-markets-monday
US Stocks Kick Off The Week In The Green, ...
04/29/2024 18:14:53

U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events...

revvity-reaffirms-its-2024-adjusted-eps-guidance-of-455-475-versus-consensus-of-465-and-organic-growth-guidance-of-1-3
Revvity Reaffirms Its 2024 Adjusted EPS Gu...
04/29/2024 10:06:32

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION